APA

Wang S., Chen F., Lin W., Wang P. & Han C. (20110131). Cytokeratin 8/18 monoclonal antibody was dissimilar to anti-cytokeratin CAM 5.2. Comment on: "A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer. Cancer Chemother Pharmacol. 2010; 65(6): 1009-1021". : Cancer chemotherapy and pharmacology.

Chicago

Wang Shao-Chuan, Chen Fong-Lin, Lin Wea-Lung, Wang Po-Hui and Han Chih-Ping. 20110131. Cytokeratin 8/18 monoclonal antibody was dissimilar to anti-cytokeratin CAM 5.2. Comment on: "A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer. Cancer Chemother Pharmacol. 2010; 65(6): 1009-1021". : Cancer chemotherapy and pharmacology.

Harvard

Wang S., Chen F., Lin W., Wang P. and Han C. (20110131). Cytokeratin 8/18 monoclonal antibody was dissimilar to anti-cytokeratin CAM 5.2. Comment on: "A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer. Cancer Chemother Pharmacol. 2010; 65(6): 1009-1021". : Cancer chemotherapy and pharmacology.

MLA

Wang Shao-Chuan, Chen Fong-Lin, Lin Wea-Lung, Wang Po-Hui and Han Chih-Ping. Cytokeratin 8/18 monoclonal antibody was dissimilar to anti-cytokeratin CAM 5.2. Comment on: "A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer. Cancer Chemother Pharmacol. 2010; 65(6): 1009-1021". : Cancer chemotherapy and pharmacology. 20110131.